ClearStar : PDMR Shareholding

29 September 2020

ClearStar, Inc.

("ClearStar" or the "Company")

PDMR Shareholdings

ClearStar (AIM: CLSU), a provider of Human Capital Integrity℠ technology-based services specialising in background and medical screening, announces that it has been notified of the following sales of ordinary shares of $0.0001 in the Company ("Ordinary Shares") by persons discharging managerial responsibilities ("PDMR"):

PDMR	Number of	Date of the	Price at which the
	Ordinary Shares	transaction	Ordinary Shares
	sold		were sold
Traci Ivester, Chief Operating Officer	22,500	28 September 2020	50.8 cents (USD) (c.
			39.5 pence)
Todd Shoulberg, President, Medical	100,000	28 September 2020	40.0 pence
Information Services

Following these transactions, Ms Ivester has an interest in 9,000 Ordinary Shares, representing 0.02% of the issued share capital of the Company, and Mr Shoulberg no longer has an interest in the Ordinary Shares of the Company.

Enquiries:

ClearStar, Inc.	[phone]
Robert Vale, Chief Executive Officer
Jennifer Balleza, Chief Financial Officer
finnCap Ltd.	[phone]
Jonny Franklin-Adams, Marc Milmo, Simon Hicks - Corporate Finance
Andrew Burdis, Tim Harper - ECM
Luther Pendragon Ltd.	[phone]
Harry Chathli, Claire Norbury, Joe Quinlan

About ClearStar

ClearStar, Inc. is a leading provider of Human Capital IntegritySM technology-based services specialising in background and medical screening. It provides employment intelligence direct to employers and via channel partners/consumer reporting agencies ("CRAs") to support better recruitment and other decisions affecting employees by increasing the quality, reliability, and visibility of information.

A seven-time Inc. 5000 honoree and founding member of the Professional Background Screening Association (formerly, 'NAPBS'), ClearStar has provided innovative technology solutions to businesses in the human capital management industry from its corporate offices in Alpharetta, Georgia since 1995. For more information about ClearStar, please visit: www.clearstar.net.

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and

persons closely associated with them

1.	Details of the person discharging managerial responsibilities / person closely associated
a)	Name		Traci Ivester
2.	Reason for the Notification
a)	Position/status		Chief Operating Officer and PDMR
b)	Initial notification		Initial notification
	/Amendment
3.	Details of the issuer, emission allowance market participant, auction platform,
	auctioneer or auction monitor
a)	Name		ClearStar, Inc.
b)	LEI			213800C2DK3HCM3R9T19
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
	each type of transaction; (iii) each date; and (iv) each place where transactions have
	been conducted
a)	Description of the Financial		Ordinary shares of US$0.0001 ("Ordinary Shares")
	instrument, type of
	instrument
	Identification code		KYG2294M1134
b)	Nature of the transaction		Sale of Ordinary Shares
c)	Price(s) and volume(s)		Price(s)	Volume(s)
				50.8 cents (USD)	22,500
d)	Aggregated information:		See (c) above
	•	Aggregated volume
	•	Price
e)	Date of the transaction		28 September 2020

f)	Place of the transaction		London Stock Exchange, AIM Market (XLON)
1.	Details of the person discharging managerial responsibilities / person closely associated
a)	Name		Todd Shoulberg
2.	Reason for the Notification
a)	Position/status		President, Medical Information Services and PDMR
b)	Initial notification		Initial notification
	/Amendment
3.	Details of the issuer, emission allowance market participant, auction platform,
	auctioneer or auction monitor
a)	Name		ClearStar, Inc.
b)	LEI			213800C2DK3HCM3R9T19
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
	each type of transaction; (iii) each date; and (iv) each place where transactions have
	been conducted
a)	Description of the Financial		Ordinary shares of US$0.0001 ("Ordinary Shares")
	instrument, type of
	instrument
	Identification code		KYG2294M1134
b)	Nature of the transaction		Sale of Ordinary Shares
c)	Price(s) and volume(s)		Price(s)	Volume(s)
				40.0 pence	100,000
d)	Aggregated information:		See (c) above
	•	Aggregated volume
	•	Price
e)	Date of the transaction		28 September 2020
f)	Place of the transaction		London Stock Exchange, AIM Market (XLON)